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The latent TGF- binding proteins (LTBP) are believed to control the availability of TGF- in the extracellular milieu. To gain
insight into the potential roles of LTBP in early development, we isolated the Xenopus LTBP-1 (xLTBP-1) cDNA. The cDNA
encodes a protein similar to the mammalian LTBP-1 in both size and domain structure. In addition, we found a novel longer
splice isoform of xLTBP. The RNAs for both forms of xLTBP displayed temporal regulation and the shorter transcript is expressed
maternally. Both transcripts also display spatial regulation and are found in the dorsal mesoderm of the organizer. In animal cap
experiments, LTBP-1 potentiates the activity of activin and nodal. The activity of LTBP-1 did not appear to require covalent
association with activin as the addition of medium containing activin and LTBP-1 to animal caps enhanced the activin effect.
These results indicate that LTBP-1 may be part of the regulatory system that establishes the threshold of morphogen activity for
activins and nodals in the dorsal side of the embryo during gastrulation. © 2002 Elsevier Science (USA)
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Signaling by members of the TGF- superfamily mediates
key roles in embryonic development. In vertebrate em-
bryos, multiple TGF--related ligands (32 in the human
genome) are involved in a variety of activities, including the
establishment of the germ layers, patterning events within
germ layers, cell fate determination, axis determination,
and cell movements. In recent years, the overall intracellu-
lar molecular signaling cascade initiated by these ligands
has been elucidated (Moustakas et al., 2001; Wrana, 2002).
This includes binding to plasma membrane serine, threo-
nine kinases, receptor cross phosphorylation, interaction of
Smad proteins with the cytoplasmic domain of the recep-
tors, phosphorylation of signaling Smads followed by
dimerization with Smad4, and migration of the complex
into the nucleus. Subsequent association of the Smad
complex with a variety of transcription factors modifies
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed. Fax: (212) 327-118gene expression both positively and negatively (Massague
and Chen, 2000; Massague and Wotton, 2000).
Whereas the intracellular aspects of TGF- signaling have
received much attention, the mechanisms regulating ligand
presentation to the receptor are less well characterized. It is
believed that upon secretion, the TGF- family members are
bound to extracellular matrix proteins from which, by an as
yet unknown mechanism, they are subsequently released
according to need and presented to the receptors. Superim-
posed upon ligand presentation to its receptor after release is
the action of secreted positive and negative regulators of both
the growth factors and their receptors. For example, molecules
such as noggin, chordin, follistatin, and cerberus are secreted
by cells of the dorsal mesoderm bind to and directly inhibit
BMPs, activins, and nodals. Also, the coreceptor one-eye
pinhead (oep) is a positive regulator of nodal activity (Grits-
man et al., 1999; Shen and Schier, 2000).
Another group of TGF- binding proteins that modulate
growth factor availability is the latent TGF- binding
proteins (LTBP) that covalently bind to the TGF- propep-
tide (Koli et al., 2001; Saharinen et al., 1999). TGF-
superfamily members are all synthesized as dimeric propro-8685. E-mail: brvnlou@rockvax.rockefeller.edu.0012-1606/02 $35.00
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teins in which the pro-domain dimer is cleaved intracellu-
larly from the mature cytokine. TGF-s 1, 2, and 3 are
unusual as their proproteins remain associated with the
mature cytokine by noncovalent interactions after secre-
tion. In order for TGF- to bind to its receptor, the cytokine
must dissociate from the propeptide. The LTBPs are disul-
fide linked to a cysteine in the TGF- propeptide. The
LTBPs (1, 2, 3, and 4) are chordate inventions and belong to
the extracellular matrix protein superfamily that includes
the fibrillins and the LTBPs. Based on in vitro experiments,
the LTBPs appear to facilitate TGF- secretion (Miyazono
et al., 1991) and activation (Flaumenhaft et al., 1989) as well
as having a structural function in the ECM (Dallas et al.,
1995). A null mutation for murine LTBP-3 results in cranial
facial and long bone defects, but embryonic development is
normal and the animals are fertile (Dabovic et al., 2002).
These phenotypes are consistent with a defect in TGF-
presentation and support the proposed role for LTBP-1, -3,
and -4 in modulating TGF- availability. LTBP-2/ mice
die during embryogenesis (E3.5–E6.5), demonstrating an
early requirement for the protein (Shipley et al., 2000).
Although LTBP-2 does not bind TGF- (Saharinen and
Keski-Oja, 2000), the early lethality of the mutant mice
suggests a critical role for LTBP-2 in development, perhaps
by binding to a signaling molecule by noncovalent interac-
tions. Loss-of-function mutations for LTBP-1 and -4 have
not been reported. Thus, despite biochemical progress, the
function, order of interactions in the extracellular space,
interactions with additional TGF- superfamily members,
and the biological integration of these functions of the
LTBPs are poorly understood.
In this study, we report first the isolation of two isoforms
of xLTBP-1 from Xenopus: a form equivalent to the mole-
cule described in other species and a novel splice variant
encoding a longer form. Both isoforms of xLTBP-1 are under
zygotic control, and expression is observed during early
gastrulation through the tadpole stage. In addition, the
shorter transcript is expressed maternally. Second, both
xLTBP-1 transcripts are expressed in dorsal mesoderm cells
of the organizer, but the long form is specific for the dorsal
marginal zone (DMZ). Third, xLTBP-1 synergizes with both
activin and nodal in mesoderm induction. Fourth, there is
selective interaction of LTBP-1 with activin and Xnr1.
Fifth, secreted LTBP-1 protein can synergize with secreted
activin, demonstrating for the first time that protein–
protein interaction between LTBP-1 and TGF- ligands is
not restricted to the intracellular secretion pathways. These
results highlight a role for LTBP-1 in modulating the




A Xenopus cDNA library made from XTC cells (Pudney et al.,
1973) was screened by using a probe derived from full-length
human LTBP-1. Positive clones were sequenced and those contain-
ing DNA sequence representing the Xenopus homologue of LTBP-1
were identified. Specific primers were designed to assemble an
open reading frame in the Xenopus expression vector CS2 (Rupp
and Weintraub, 1991; Turner and Weintraub, 1994). The following
primers were used to generate seven partial clones: Fragment 1:
XLTBP1 U1; 5-GGC GGC CGC ACC ATG GAT ACC AAG CTC
ATA-3; xLTBP1-D1; 5-GGC ACT GTG GTA AGA GAA CT-3,
Fragment 2: xLTBP1-U2; 5-TGG GAG TTC CTC GTC TAC
AC-3, xLTBP1-D2 5-CAG GAA CAG GGC ATT TGT CG-3,
Fragment 3: xLTBP-U3: 5-TCT GCT GTT GCA CCG TGG GA-3;
xLTBP1-D3: 5-TTT TCA CAT CGG CCA TGG GA-3, Fragment
4: xLTBP1-D4: 5-ATT GAT CCC CAG ATG GAG CT-3, xLTBP1-
U4: 5-AAT GAA TGC GCC AAG GAT CC-3, Fragment 5:
xLTBP1-D5a: 5-CTG AAG TAG TAA GAC CTT GT-3, xLTBP1-
U5a: 5-CCT AAT GGG GAA TGT CTC AA-3, Fragment 6:
xLTBP1-U6: 5-GAG CTG GAT GGG GAG ATA AT-3, xLTBP1-
D6: 5-GTC TAT AAG AGC ATC ATG TC-3, Fragment 7:
xLTBP1-U7: 5-GAC TAT GCC GAA CTT TGC AA-3, xLTBP1-
D7: 5-GGC GGC CGC TAT TAC TCA AGT TCA CTG TCG-3.
The fragments were assembled by using unique restriction sites to
yield the full-length clone. Primers for RT-PCR analysis were:
xLTBP 3s; 5-CCT ATG ACA GGG TAT TGC CGA-3 and
xLTBP1-D5, 5-ATT CAT CAG AAC CTA TGA C-3. These
primers amplify both the long and short forms of Xenopus LTBP-1,
286 and 208 base pairs, respectively. RT-PCR assays were as
described previously (Altmann et al., 2001; Wilson and Hemmati-
Brivanlou, 1995). Primers: chordin (Chd) (Sasai et al., 1994), Wnt8
(Smith and Harland, 1991), OtxA (otx) (Lai et al., 1995), Brachyury
(xBra) (Smith et al., 1991), Xhox3 (Ruiz i Altaba and Melton, 1989),
goosecoid (gsc) (Cho et al., 1991), Sox17a (Hudson et al., 1997),
ornithine decarboxylase (ODC) forward 5-CAA CGT GTG ATG
GGC TGG AT-3, reverse 5-CAT AAT AAA GGG TTG GTC TCT
GA-3. The sequence of xLTBP has been submitted to Gen Bank.
In Situ Hybridization
Antisense RNA probe was prepared by linearizing xLTBP-1
CS2 with Sal I and transcribing with T3 RNA polymerase
according to manufacturer’s instructions with digoxygenin. Whole-
mount in situ hybridization was performed as described (Harland,
1991). Embryos to be sectioned were embedded in 20% gelatin/PBS
and cut on a vibratome at either 50 or 100 m.
RNA Preparation, Injection, and Microsurgery
RNA was prepared in vitro by using Ambion Message Machine
and the appropriate polymerase from the following vectors:
xLTBP1 CS2 AscI/Sp6, hLTBP1 (Kanzaki et al., 1990), pSP64T
activin-HA EcoRI/Sp6, (Liem, Jr. et al., 1997), xNRI CS2 NotI/
Sp6. Embryos were injected at the stage indicated in the figure
legends, and tissue explants were isolated and processed for RT-
PCR as described previously (Kay and Peng, 1991). To prepare
soluble proteins, Xenopus ovaries were surgically removed from
anesthetized adult females and oocytes were manually dissected.
Oocytes were injected with 50 pg of capped mRNA, cultured
overnight in OR2 media containing 100 g/ml acetylated BSA.
Tissue explants were dissected from injected or uninjected em-
bryos from the regions indicated in the figure legends and cultured
to the stages indicated. Explants and embryos were cultured in
0.1–0.5 MMR (Peng, 1991)
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FIG. 1. Xenopus LTBP-1 sequence and analysis. (A) Primary sequence of the short form of Xenopus LTBP-1 and its translation product.
Primers used to isolate the cDNA are indicated by arrows. Red arrows indicate the RT-PCR primers. Color key: yellow boxes indicate
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Cell Culture and Conditioned Media
Serum-free conditioned media from CHO cells or CHO cells
expressing human LTBP-1 (clone 22 gift of J. Annes) were concen-
trated 20-fold in a Centricon-100 (Amicon). Concentrated media
were diluted 2-fold in 0.5 MMR (to promote healing of the
dissected animal caps) and applied to animal cap explants dissected
at the blastula stage (stage 9) (Kay and Peng, 1991). Recombinant
activin protein (produced in oocytes) was added at a dose sufficient
to induce ventral mesoderm marker expression. Explants were
incubated for 2 h at room temperature, and then placed at 16°C
overnight, prior to harvesting the RNA at stage 13.
RESULTS
Cloning and Characterization of xLTBP-1 cDNAs
To isolate the xLTBP-1, a cDNA library derived from the
Xenopus XTC cell line was screened by using a human
FIG. 2. RT-PCR analysis of Xenopus LTBP-1 expression. Tempo-
ral expression of Xenopus LTBP-1. The two alternative forms are
detected by using a single primer pair indicated in Fig. 1A.
Transcripts are detected after 25 cycles. ODC is a loading control.
EGF-like domains predicted by SMART with the domains separated by red boxes; red text indicates RGD cell binding site; gray box is the
signal sequence; green box is the signal cleavage site; blue boxes are cysteine-rich repeats; the black box indicates the location of the
25-amino-acid deletion GTNSFGESNNDSLLNTFSPSVTHDNT. (B) Diagram of Xenopus LTBP-1 indicating the domain structure. (C)
Sequence alignment of Xenopus, human, and mouse LTBP-1. Conserved residues are boxed. Blue text indicates amino acids conserved
between two of the three species. Bold text indicates amino acid similarity.
121LTBP-1 in Embryonic Development
© 2002 Elsevier Science (USA). All rights reserved.
LTBP-1 cDNA as a probe. A number of positive clones
derived from this screen encoded sequences homologous to
the human LTBP-1. Specific primers derived from the XTC
clones were generated to cover the complete cDNA and
assemble the open reading frame (ORF) of xLTBP-1 into the
expression vector pCS2 (see Materials and Methods).
The nucleotide and amino acid sequences of xLTBP-1 are
shown in Fig. 1A. xLTBP-1 contains 1418 amino acids and
has, in addition to the signal sequence, 4 cysteine rich (CR1,
-2, -3, -4) domains and 17 EGF-like repeats. This domain
structure (Fig. 1B) is homologous to the human, mouse, and
rat forms of LTBP-1 (Koli et al., 2001; Saharinen et al.,
1999). Interestingly, a second xLTBP-1 clone derived from
the Xenopus cell line has an insertion amino-terminal to
the third CR3 domain of 26 amino acids with the sequence
101GTNSFGESNNDSLLNTFSPSVTHDNT127. This variant
of LTBP-1 has not been described in any other species. The
alignment of amino acid sequences between human,
mouse, and Xenopus (when the extra sequences in the CR3
domain are excluded) shows that the proteins share about
65% identity (Fig. 1C).
Embryonic Expression of xLTBP-1
To address the temporal expression pattern of the two
xLTBP-1 RNAs during embryonic development, we used
RT-PCR analysis to screen embryos of different stages. A
single primer pair designed to detect both sets of transcripts
(with and without the insertion before the third CR3
domain) was used to determine whether there was a differ-
ence in the timing of expression of the two RNAs. Figure 2
shows that the short form of xLTBP-1 (xLTBP-1b) is ex-
pressed maternally (lane 1) as early as the 16-cell embryo
stage, prior to the initiation of zygotic transcription (lane 2).
Expression of the RNA continued throughout zygotic de-
velopment. Interestingly, between stages 10 and 15, expres-
sion decreased but increased in later stages. The long form
of xLTBP-1 (xLTBP-1a) was not expressed maternally, but
begins to be expressed during gastrulation at the same time
as the short form. Therefore, expression of the two alterna-
tively spliced forms of xLTBP-1 is temporally regulated.
We next asked whether xLTBP-1 mRNA is expressed in a
spatially restricted manner during embryogenesis. In order
to address this question, we performed in situ hybridiza-
tions on whole embryos using an antisense xLTBP-1 probe
that recognizes both transcripts. We found that xLTBP-1
RNA expression is dynamic during embryogenesis but is
never ubiquitous. Figure 3A shows that xLTBP-1 message is
detected at the start of gastrulation in the dorsal mesoderm
in the organizer. Within the organizer, expression is con-
fined to the cells of the axial mesoderm, which later form
the prechordal plate and notochord (Fig. 3B; see *). Follow-
ing gastrulation, during neural plate stages, the expression
of xLTBP-1 RNA is restricted to the posterior half of the
embryo (Fig. 3C). At this stage, no expression is seen in the
anterior neural plate. At stage 25, transcripts are detected
within the spinal cord and but not in the forebrain (Fig. 3D).
A section through the spinal cord shows strong expression
in the axial mesoderm and the neural tube (Fig. 3E). By stage
28, xLTBP-1 is detected within the forebrain, hindbrain, and
spinal cord (Fig. 3F). A posterior to anterior gradient of
expression is observed in the somites of the paraxial meso-
derm. At this stage, xLTBP-1 is expressed in both the
roofplate (see white arrow, Fig. 3G) as well as the floorplate
(black arrow) of the posterior region of the spinal cord. In
addition to the axial mesodermal expression, xLTBP-1 tran-
scripts begin to be expressed in the anterior wall of the
telencephalon, roof plate of the midbrain, and rhom-
bomeres 1, 3, and 5 (Fig. 3H). By stage 35, cranial expression
of xLTBP-1 RNA also includes pharyngeal pouches 1, 2, and
3, the photoreceptors of the eye, the cement gland, cranial
ganglia, and nerves VII (Geniculate) and IX (Glossopharyn-
geal) (Fig. 3I). Finally, at tailbud stages, a high level of RNA
is expressed in the tailbud or cordoneural hinge, a region
previously demonstrated to be endowed with organizing
activity (Fig. 3J). Expression can also be detected in the
heart (see white arrow).
To examine the spatial expression of the two xLTBP-1
forms during gastrula stages by a biochemical approach, we
isolated the dorsal and ventral marginal zones of a stage 11
gastrula and performed RT-PCR analysis using the same
primers as for Fig. 2A but for additional cycles to enhance
the signal. The results from this experiment confirmed
xLTBP-1 expression at gastrula stage 11 (Figs. 2 and 3K).
Expression was shown to be primarily restricted to the
dorsal marginal zone and only low levels of expression were
observed in either the animal pole or ventral marginal zone.
In addition, expression of the long form is restricted to the
dorsal marginal zone. The additional markers included in
Fig. 3K are controls for the dissection and rule out contami-
nation. Thus, the two forms of xLTBP-1 mRNA show both
temporal and spatial expression specificity. The common
denominator among the cells expressing xLTBP-1 RNA is
that they belong to organizing centers in the embryo. Given
the ubiquity of various TGF- superfamily members
throughout the embryo, the highly dynamic but restricted
expression of xLTBP-1 supports the hypothesis that
xLTBP-1 activities are limited to specific TGF- family
ligands.
xLTBP-1 Synergizes with Activin and Xnr1 in
Mesoderm Induction
To characterize the embryological activity of LTBP-1, we
tested the inducing ability of both human and Xenopus
LTBP-1 in the context of ectodermal explants. When micro-
dissected from blastula-stage embryos, animal cap explants
will differentiate into epidermis (Wilson and Hemmati-
Brivanlou, 1995). However, if these explants are exposed to
activins or nodals, they adopt a mesodermal fate (Gurdon et
al., 1994). To test whether LTBP-1 affected cell fate, we first
performed a dose-response experiment in which increasing
concentrations of sense RNA encoding hLTBP-1 were mi-
croinjected in the animal poles of two-cell-stage blas-
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tomeres (Figs. 4A and 4B). The injected embryos, along with
their sibling controls, were allowed to develop to blastula
stages, at which point animal caps were removed, cultured
until controls reached gastrula stages, and assayed for the
expression of cell type molecular markers by RT-PCR.
When injected alone, even at high doses (2 ng/embryo),
hLTBP-1 mRNA does not induce molecular markers for
endoderm (Sox 17), organizer (cerberus, goosecoid, or chor-
din), mesoderm (Xbra), and ventral mesoderm (Xwnt8 and
Xhox3) (Fig. 4A, lane 2; Fig. 4B lane 3). This result suggests
that this hLTBP-1 RNA cannot independently induce me-
sodermal or endodermal cell fates in pluripotent explants.
In contrast, activin RNA, when injected alone at low
concentrations, induces the expression of ventral meso-
derm and endoderm markers (Fig. 4A, lane 3; Xwnt8 and
Xhox3, Sox17). As the concentration of activin is in-
creased, markers of dorsal mesoderm and organizer are
detected in addition to the ventral markers (Fig. 4A, lanes 4
and 5, cerberus, goosecoid, chordin). When activin and
hLTBP-1 are coexpressed, the level of activin required to
induce the expression of dorsal markers is reduced to the
lowest amount tested (0.5 pg activin). Similar enhancement
is observed when LTBP is coexpressed with AXnr-1 in
which the prepro region of activin is fused to Xenopus nodal
related-1 (Fig. 4A, lanes 9–14). To determine whether the
observed interaction was due to the presence of the activin
prepro region, we examined the effect of hLTBP-1 on native
Xenopus Xnr-1 (Fig. 4B). When injected alone, Xnr-1 did not
induce the organizer genes chordin and cerberus nor the
endoderm marker Sox17 (Fig. 4B, lane 1). When Xnr-1 and
were hLTBP-1 coinjected, high levels of expression of chor-
din, cerberus, and Sox17 were observed. In addition, ex-
pression of the ventral marker Xwnt8 was decreased, while
the pan-mesodermal marker Brachyury was induced. These
results demonstrate synergism between hLTBP and both
activin and nodal during mesoderm induction.
In addition to increasing the relative activity of activin,
the coexpression of activin and hLTBP-1 changes the char-
acter of the mesoderm induced. Whereas high concentra-
tions of activin result in the expression of dorsal markers
together with ventral markers (Fig. 4A, lane 5), coexpres-
sion with hLBTP-1 suppresses the expression of the ventral
markers (Fig. 4A, lane 8; Wnt8 and Xhox3), while enhancing
the expression of dorsal markers (Fig. 4A, lane 8; cerberus,
goosecoid, chordin). These changes in the character of the
induced mesoderm are also observed when Xnr-1 is coex-
pressed with hLTBP-1 (Fig. 4B, lanes 1 and 2). This effect
can take place by increasing the overall concentration of
these molecules, therefore promoting more dorsal fates,
both by affecting the secretion of these ligands, as well as
through direct extracellular interactions (as we have dem-
onstrated for LTBP-1 and activin). However, whether the
extracellular binding of LTBP-1 to activin changes the
properties of activin signaling is unknown, although plau-
sible. For instance, this could have an effect at the level of
differential receptor interaction, competitive binding for
activin antagonists, etc. Similarly, it is unclear whether
LTBP-1 can bind multiple TGF- ligands simultaneously,
and what effects this might have in mesodermal patterning.
Most organizer-specific secreted factors are inhibitors of
signaling pathways. For example, follistatin inhibits activin
and BMP11 signaling (Fainsod et al., 1997; Hemmati-
Brivanlou et al., 1994), DKK inhibits the Wnt pathway
(Glinka et al., 1998), Cerberus inhibits BMP, nodal, and
Wnt signaling (De Robertis et al., 1997; Glinka et al., 1997),
and Noggin, Chordin, and Xnr3 inhibit BMP/GDF signaling
(Wessely and De Robertis, 2002). Therefore, we tested
whether LTBP-1 was acting as an inhibitor using the animal
cap assay. We found that LTBP-1 does not act as a neural
inducer when expressed in ectodermal cells (data not
shown). This eliminated the possibility that LTBP-1 was
acting as an inhibitor of the BMPs, since inhibition of
BMP/GDF signaling is the signature of neural induction in
amphibian explants. Thus, in addition to synergism be-
tween activin/nodal, the thresholds for induction of meso-
derm are differentially affected by the presence of LTBP.
To test whether LTBP-1 can interact with activin in the
extracellular space, in addition to its role in secretion of
TGF- ligands, we prepared both activin and hLTBP-1
proteins and assayed them in the context of the animal cap
explants. When activin protein is added alone to tissue
explants at low doses, ventral mesoderm is induced (Fig. 5,
lane 5; xBra, Wnt8, Hox-B9). hLTBP-1 protein from condi-
tioned medium mixed with activin protein induces the
expression of dorsal markers (Fig. 5 lane 6; chordin, myoD,
coll-type II). Thus, LTBP protein acts as an agonist modifier
of activin ligands. This result demonstrates that LTBP-1
can interact with ligands in the extracellular space in a
manner independent of its interactions in the secretory
pathway.
DISCUSSION
Xenopus LTBP-1 is expressed in two temporally and
spatially regulated forms during development. The short
form is expressed maternally and levels of this transcript
decline through blastula stages until zygotic expression of
both the long and short forms is detected. The localization
of xLTBP-1 to the dorsal region, and in particular the dorsal
marginal zone, suggested the involvement of xLTBP-1 in
mesoderm and neural induction. In animal cap explants,
the RNA injection of our LTBP-1 RNA was not capable of
inducing either mesoderm or neural tissues, suggesting that
the presence of the appropriate ligand was required. Indeed,
we have shown that xLTBP-1 enhances the activities of
activin and Xnr1.
In Vivo Function of LTBP-1 in Embryonic Axis
Formation
A possible in vivo function of xLTPB1 is to potentiate
locally the activities of the organizer specific mesoderm
inducers of the activin and nodal pathways. The ability of
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LTBPs to interact with the extracellular matrix (Koli et al.,
2001; Saharinen et al., 1999; Unsold et al., 2001) suggests
that xLTBP-1 may restrict the diffusion of activin/nodal
molecules in both the embryo and the formation of the
primary axis, resulting in higher local levels of activity of
these two signaling molecules. A requirement of LTBP for
the formation of the axis is not directly addressed in these
studies. However, the coordinate expression of xLTBP-1
with its cognate ligands suggests that xLTBP-1 may be
required for proper activin/nodal function in the developing
embryo. This hypothesis is consistent with the embryonic
lethal phenotype observed with the loss-of-function of
FIG. 3. In situ hybridization of Xenopus LTBP-1. (A–J) In situ hybridization. (A): Stage 10.5 (gastrula). Expression of xLTBP-1 is detected
within the organizer region. (B) A section (depicted by the line “i” in A) shows expression is restricted to the dorsal mesoderm of the
organizer (*). (C) Stage 20. Expression of xLTBP-1 in the spinal cord. No expression is seen in the anterior neural plate at this stage.
Anterior/ventral is to the right. (D) Stage 25. Transcripts can be detected throughout the spinal cord region but still not in anterior domains.
(E) A section through the embryo at the level of the spinal cord (indicated by the line “ii” in D); xLTBP-1 RNA expression is seen throughout
the neural tube but not in the notochord at this stage. (F) Expression is also detected in the lateral plate mesoderm, Stage 28. Expression
is seen in the tail, throughout the spinal cord and in the hindbrain. (G) Transverse section through the spinal cord (“iii” in F); xLTBP-1 RNA
is expressed in the mesoderm lateral to the neural tube, in the notochord and in both the roof (white arrow) and floor plates (black arrow).
(H) Midsagital section through the head (line “iv” in F). xLTBP-1 RNA is also expressed in anterior regions, in the hindbrain, and in the
ventral forebrain. Note the expression within the notochord. (I) Stage 35. xLTBP-1 RNA is highly expressed in the muscle blocks
surrounding the spinal cord. It is also expressed in the rhombomeres of the hindbrain, the eye, and the cement gland. High expression is
present in the tailbud cordoneural hinge. (J) Stage 42. Additional xLTBP-1 RNA expression is observed in more anterior regions, including
the heart (white arrow), the branchial arches, and around the eye. anp, anterior neural plate; cg, cement gland; ey, eye; fb, forebrain; hb,
hindbrain; he, heart; nc, notochord. Locations of the sections are indicated by dashed lines. (K) xLTBP-1 RNA expression in dissected
gastrula embryos: Dorsal and ventral marginal zones and animal cap explants were dissected from stage 11 gastrula embryos and analyzed
by RT-PCR. xLTBP-1 was amplified by using the same primers as in Fig. 2 but for 30 cycles. The following controls are included as markers
for the dissected fragments: Chordin (chd) for dorsal mesoderm, Wnt8 for ventral mesoderm, Otx for animal cap, Brachyury (xBra) as a pan
mesodermal marker, and ODC as the loading control.
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LTBP-2 (Shipley et al., 2000). Further studies are required to
examine the ligand specificities of xLTBPs. However, the
differences in activities observed for TGF- ligands and
their receptors strongly support the idea of additional ligand
binding in the LTBP family.
Role of LTBP-1 in Signaling among the Cells of the
Organizer
Our studies also demonstrate the localization of the long
form of xLTBP-1 to the organizer and illustrate the ability of
xLTBP-1 to act as an agonist in both activin and nodal
signaling. Thus, in the context of the organizer, LTBP-1
would be required for organizer function. Interestingly,
antagonists of TGF- signaling are also expressed at the
same time and place as the ligands and their binding
proteins. The consequences of expression of these compet-
ing activities is not known but may contribute to maintain-
ing a high local ligand concentration and activity, while
inhibiting activin/nodal signaling at a distance.
LTBP-1 in the TGF- Signaling Cascade
The LTBPs are important for the secretion of TGF-1, -2,
and -3 and this requires covalent interactions between the
two molecules (Dabovic et al., 2002; Flaumenhaft et al.,
1989; Miyazono et al., 1991). No noncovalent interactions
between the TGF-s and LTBPs have been reported and
attempts to show such interactions were inconclusive (un-
published observations). Our finding that conditioned me-
dium containing LTBP-1 can potentiate the activity of
activin indicates a physical interaction between activin and
LTBP that enhances the potency of activin signaling. Al-
though we have not yet demonstrated direct physical asso-
ciation between LTBP-1 and activin, the data suggest that
the LTBPs and the related family members, the fibrillins,
may have a role in controlling the activities of additional
TGF- superfamily members. The recent report (Arteaga-
Solis et al., 2001) describing syndactyly related to a failure
of BMP-4 signaling in mice containing a null mutation in
the fibrillin-2 gene is consistent with such an interaction.
As noted above, the organizer is a source of antagonists
(follistatin), the signaling molecules (activin/nodal), and
agonists (LTBP-1). It is not clear how these three kinds of
molecules interact within the organizer. We are currently
examining whether LTBP/follistatin/activin ternary com-
plexes form and interaction of LTBP with activin blocks
follistatin binding to activin.
FIG. 4. Gain-of-function analysis of hLTBP-1 in animal cap explants. (A) Coexpression of hLTBP-1 with TGF- family ligands: Embryos
were injected in the animal pole of both blastomeres at the two cell stage. Amounts of RNA injected were: 0.2 ng hLTBP-1; 0.5, 1.0, and
2.0 pg activin with and without hLTBP-1; 0.1, 0.2, 0.5 ng AXnr-1 with and without hLTBP-1. Animal explants were isolated at stage 9 and
cultured until sibling controls reached stage 11 and processed for RT-PCR as described. (B) Coexpression of hLTBP-1 with Xenopus nodal
related-1. Xnr-1 (100 pg/embryo) was injected with or without hLTBP-1 (500 pg/embryo). Animal explants were isolated at stage 9 and
cultured until sibling controls reached stage 11 and processed for RT-PCR as described. xBra, brachyury (pan-mesodermal marker);
Cerberus, Chordin (dorsal mesendodermal markers); goosecoid (dorsal mesoderm marker); XWnt-8 (ventral mesodermal marker); Xhox3
(ventral mesodermal marker); Sox17 (endodermal marker); EF1-, elongation factor alpha (loading control).
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Morphogen Thresholds
Recent studies have demonstrated that both activin and
nodals can act as morphogens establishing different fates at
different activity thresholds (Chen and Schier, 2001; Kod-
jabachian, 2001; McDowell et al., 2001). We have shown
that LTBP-1 modulates the morphogen activities of activin
and Xnr-1, and potentially other related ligands. Therefore,
LTBPs might function to promote the morphogenic activi-
ties of these molecules in the embryo. This is important in
the context of activin signaling, as the role of activin as a
morphogen has been questioned because of its expression
pattern in the mesoderm. Whereas nodals are confined to
the organizer region, activins are expressed ubiquitously in
the embryo as illustrated by in situ hybridization. Morpho-
gen experiments have demonstrated that high thresholds of
activin give rise to axial dorsal mesoderm, whereas low
levels yield mesoderm of ventral character (Gurdon et al.,
1994). Our results indicate that the higher threshold of
activin activity might be created by LTBP in the organizer.
If we assume that activin protein distribution is homog-
enous in the embryo (i.e., reflects the distribution of the
RNA as detected by in situ hybridization), the presence of
LTBP-1 in the dorsal side aspect will specifically increase
activin activity in the organizer cells. It is thus tempting to
speculate that the two extremes of the activin gradient are
modulated dorsally by processing factors such as LTBP and
ventrally by the BMP/GDFs, which are expressed in the
ventral lateral region of the embryo. The fact that our study
shows that LTBP-1 can specifically interact with activin is
in support of LTBP being involved in the high threshold
gradient of activin activity. Future studies will address how
LTBP activity helps refine activin/nodal morphogen signal-
ing in the context of other modulators of TGF- signaling in
the embryo.
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